Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Dehydrogenase
    (4)
  • DNA/RNA Synthesis
    (2)
  • Apoptosis
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

dhodh in 1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
DHODH-IN-1
T110191800296-63-2In house
DHODH-IN-1 is a potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 25 nM. DHODH-IN-1 is an inhibitor of the pyrimidine biosynthetic pathway.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
RORγt/DHODH-IN-1
T641452764662-15-7
RORγt DHODH-IN-1 (compound (R)-14d) is a potent, orally active dual inhibitor of RORγt (IC50: 0.083 μM) and DHODH (IC50: 0.172 μM), exhibiting significant in vivo anti-inflammatory effects.
  • Inquiry Price
10-14 weeks
Size
QTY
hDHODH-IN-1
T115461173715-42-8
hDHODH-IN-1 is a human dihydroorotate dehydrogenase (hDHODH) inhibitor exhibiting anti-inflammatory properties.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
CHIKV-IN-2
T93942361289-44-1
CHIKV-IN-2, a chemical compound, exhibits potent inhibitory activity against the enzyme Dihydroorotate Dehydrogenase (DHODH), crucial for pyrimidine synthesis affecting various viruses' replication. It serves as an effective Chikungunya virus (CHIKV) inhibitor, demonstrating significant cellular antiviral activity (EC90=270 nM) and enhanced liver microsomal stability[1].
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Farudodstat
ASLAN003
T103841035688-66-4
Farudodstat (ASLAN003) is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) with antitumor activity, showing potential as a first-in-class candidate in AML [Acute Myeloid Leukemia].
  • Inquiry Price
Size
QTY
RORγt/DHODH-IN-2
T624622641758-86-1
RORγt DHODH-IN-2 (compound 1) is a potent dual inhibitor of RORγt and DHODH, useful for studying inflammatory bowel disease (IBD).
  • Inquiry Price
6-8 weeks
Size
QTY
RORγt/DHODH-IN-3
T64146
RORγt DHODH-IN-3 (compound (S)-14d) is a potent, orally active dual inhibitor of RORγt (IC50: 0.098 μM) and DHODH (IC50: 0.432 μM) with significant in vivo anti-inflammatory effects.
  • Inquiry Price
10-14 weeks
Size
QTY
hDHODH-IN-12
T78932
hDHODH-IN-12 is a potent inhibitor of dihydroorotate dehydrogenase (DHODH), exhibiting an inhibitory concentration (IC50) of 0.421 μM. As the rate-limiting enzyme in the de novo synthesis of pyrimidines, critical for DNA RNA synthesis, DHODH is localized within the inner membrane of human mitochondria. hDHODH-IN-12 is applicable in lung cancer research [1].
  • Inquiry Price
Size
QTY
DHODH-IN-24
T86188418775-30-1
DHODH-IN-24 (compound 16) serves as a powerful inhibitor of human dihydroorotate dehydrogenase (DHODH), exhibiting an IC50 value of 91 nM [1].
  • Inquiry Price
6-8 weeks
Size
QTY
DHODH-IN-25
T861892619531-95-0
DHODH-IN-25 (Compound 25) serves as an orally active inhibitor of dihydroorotate dehydrogenase (DHODH), exhibiting a potent IC50 of 5.4 nM against human DHODH. It is applicable in research related to acute myeloid leukemia (AML) [1].
  • Inquiry Price
10-14 weeks
Size
QTY